Atrial Fibrillation

Healio and Cardiology Today have aggregated a list of the most-read news in cardiology of September 2022.

In a survey conducted for Atrial Fibrillation Awareness Month, researchers found that more than one-quarter of adults with AF have fears about their diagnosis, but many do not feel the urgency to get treated immediately.

An artificial intelligence algorithm applied to existing ECGs in adults at high risk for stroke can identify signatures of atrial fibrillation risk during normal sinus rhythm, researchers reported in The Lancet.

Very high-powered short-duration radiofrequency ablation for atrial fibrillation with 90 W using a next-generation catheter was safe and effective vs. high-powered short-duration 50 W radiofrequency ablation, researchers reported.

Among patients who had catheter ablation for atrial fibrillation, women were more likely than men to require hospitalization for more than 1 day, to have major adverse events and to have poor quality of life outcomes, researchers reported.

Risk for incident atrial fibrillation was higher in those who habitually used fish oil supplementation compared with those who did not, researchers reported in the European Journal of Preventive Cardiology.

Wearable devices may play a significant role in the future of kidney care, according to a presenter at the International Conference on Dialysis.

BOSTON — In this Healio video exclusive, Dipti Itchhaporia, MD, FACC, FESC, discusses some of the highlights in late breaking science presented at TCT 2022.

BOSTON — At 3 years, the Amplatzer Amulet device remained superior at left atrial appendage occlusion and noninferior for safety and effectiveness compared with the Watchman device, researchers reported at TCT 2022.

In this edition, new cannabinoids hold promise for medical applications; Theranica secures $45 million for migraine treatment device and more.